Increased Intraplatelet ADMA Level May Promote Platelet Activation in Diabetes Mellitus

BACKGROUND: Antiplatelet therapy has become a standard therapeutic approach in the secondary prevention of cardiovascular system disorders of thrombotic origin. Patients with concomitant diabetes mellitus (DM) obtain fewer benefits from this treatment. Hence, the pathophysiology of altered platelet...

Descripción completa

Detalles Bibliográficos
Autores principales: Gawryś, Jakub, Wiśniewski, Jerzy, Szahidewicz-Krupska, Ewa, Gajecki, Damian, Leśniewska, Julia, Majda, Filip, Gawryś, Karolina, Fortuna, Paulina, Mlynarz, Piotr, Doroszko, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542534/
https://www.ncbi.nlm.nih.gov/pubmed/33062144
http://dx.doi.org/10.1155/2020/6938629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542534/
https://www.ncbi.nlm.nih.gov/pubmed/33062144
http://dx.doi.org/10.1155/2020/6938629

Ejemplares similares